Alliance Bernstein - AB International Growth ETF
IGGY
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.28B
Close$
Share Statistics
| Market cap | $1.28 Billion |
|---|---|
| Enterprise Value | $1.28 Billion |
| Dividend Yield | $- (NaN%) |
| Earnings per Share | $- |
| Beta | 1.22 |
| Outstanding Shares | - |
Return
| Return on Equity | -65.18% |
|---|---|
| Return on Assets | -46.21% |
| Return on Invested Capital | 22.08% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 270.46 |
| Enterprise Value to Net Income | -117 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Eyegate Pharmaceuticals Inc
CEO: Stephen From BUFM actively manages FLEX options in efforts to participate in the price return of the SPDR S&P 500 ETF (SPY), up to a cap, and provide partial downside protection over an outcome period that ranges from 90 to 120 days. In exchange for ...